Vertex Pharmaceuticals (VRTX)
(Delayed Data from NSDQ)
$488.98 USD
-1.87 (-0.38%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $488.20 -0.78 (-0.16%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: AMC |
6/2024 | $4.14 | -0.80% |
Earnings Summary
For their last quarter, Vertex Pharmaceuticals (VRTX) reported earnings of $4.76 per share, beating the Zacks Consensus Estimate of $4.10 per share. This reflects a positive earnings surprise of 16.10%. Look out for VRTX's next earnings release on August 01, 2024. For the next earning release, we expect the company to report earnings of $4.14 per share, reflecting a year-over-year increase of 6.43%.
Earnings History
Price & Consensus
Zacks News for VRTX
Vertex Pharmaceuticals (VRTX) Exceeds Market Returns: Some Facts to Consider
VRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services